Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|March 28, 2003
Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in childrenElaine J Abrams, Jeffrey Wiener, Rosalind Carter, et al.
The Pediatric Infectious Disease Journal|December 1, 2017
Defining Study Outcomes That Better Reflect Individual Response to TreatmentKonstantia Angelidou, Paul Palumbo, Jane Lindsey, et al.
Clinical Pharmacology and Therapeutics|December 10, 2003
Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationshipsDolors Soy, Francesca T Aweeka, Joseph A Church, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 StudyCindy Vavro, Theodore Ruel, Andrew Wiznia, et al.
Journal of Clinical Pharmacology|March 6, 2003
Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and childrenEdmund V Capparelli, Janet A Englund, James D Connor, et al.
Retrovirology|October 15, 2009
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5AMainul Hoque, Hartmut M Hanauske-Abel, Paul Palumbo, et al.
Plos One|December 7, 2013
Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African childrenIris Chen, Leila Khaki, Jane C Lindsey, et al.
Pageof 6